Skip to main content

and
  1. No Access

    Article

    Critical analysis of antibacterial agents in clinical development

    The antibacterial agents currently in clinical development are predominantly derivatives of well-established antibiotic classes and were selected to address the class-specific resistance mechanisms and determi...

    Ursula Theuretzbacher, Karen Bush, Stephan Harbarth in Nature Reviews Microbiology (2020)

  2. Article

    Author Correction: Interplay between β-lactamases and new β-lactamase inhibitors

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Karen Bush, Patricia A. Bradford in Nature Reviews Microbiology (2019)

  3. Article

    Publisher Correction: Interplay between β-lactamases and new β-lactamase inhibitors

    In figure 1 of the above article, the structure of ETX2514 was missing a double bond and methyl group. This has now been corrected in the PDF and online. The publisher apologizes to the authors and to the read...

    Karen Bush, Patricia A. Bradford in Nature Reviews Microbiology (2019)

  4. No Access

    Article

    Interplay between β-lactamases and new β-lactamase inhibitors

    Resistance to β-lactam antibiotics in Gram-negative bacteria is commonly associated with production of β-lactamases, including extended-spectrum β-lactamases (ESBLs) and carbapenemases belonging to different m...

    Karen Bush, Patricia A. Bradford in Nature Reviews Microbiology (2019)

  5. Article

    In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline

    Eravacycline is a novel, fully synthetic fluorocycline antibiotic of the tetracycline class being developed for the treatment of complicated urinary tract infections and complicated intra-abdominal infections....

    Yunliang Zhang, **aoyan Lin, Karen Bush in The Journal of Antibiotics (2016)

  6. No Access

    Article

    Tackling antibiotic resistance

    The increasing levels of antibiotic resistance observed in clinical isolates, coupled with a lack of new drugs coming through the development pipeline, make the problem of antibiotic resistance a global crisis...

    Karen Bush, Patrice Courvalin, Gautam Dantas, Julian Davies in Nature Reviews Microbiology (2011)

  7. Article

    Inhibition of metallo-β-lactamases by pyridine monothiocarboxylic acid analogs

    Deborah M Roll, Youjun Yang, Mary Jo Wildey, Karen Bush in The Journal of Antibiotics (2010)

  8. Article

    Preparation of Erythromycin Analogs Having Functional Groups at C-15

    Chemobiosynthesis has been used to prepare analogs of erythromycins having unique functional groups at the 15-position. Using diketide thioester feeding to genetically engineered Streptomyces coelicolor, analogs ...

    Gary W Ashley, Mark Burlingame, Ruchir Desai, Hong Fu in The Journal of Antibiotics (2006)

  9. Article

    15-Amido Erythromycins: Synthesis and in Vitro Activity of a New Class of Macrolide Antibiotics

    An array of 15-amido substituted erythromycin A compounds was synthesized using a chemobiosynthesis approach. It was found that while the in vitro antibacterial activities of aryl amides were inferior to erythrom...

    Simon J Shaw, Darren Abbanat, Gary W Ashley, Karen Bush in The Journal of Antibiotics (2005)

  10. No Access

    Article

    Activity of sulfa drugs and dihydrofolate reductase inhibitors againstCandida albicans

    Growth ofCandida albicans can be inhibited by sulfa drugs which prevent biosynthesis of folic acid. The dihydrofolate reductase (E.C. 1.5.1.3) inhibitors aminopterin and methotrexate also exhibit anticandidal act...

    Karen Bush, Joan S. Freudenberger, Dorothy S. Slusarchyk, R. B. Sykes in Experientia (1982)